Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2000 2
2001 11
2002 12
2003 12
2004 7
2005 7
2006 18
2007 3
2008 6
2009 6
2010 4
2011 5
2012 1
2017 2
2018 2
2019 2
2020 0
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 15111452

100 results
Results by year
Filters applied: . Clear all
Page 1
Drug therapy for Alzheimer's disease.
Kavanagh S, Kabathova P. Kavanagh S, et al. CMAJ. 2004 Apr 27;170(9):1371-2; author reply 1372-4. doi: 10.1503/cmaj.1031912. CMAJ. 2004. PMID: 15111452 Free PMC article. No abstract available.
[Galantamine (reminyl) in the treatment of Alzheimer's disease and vascular dementia].
Gavrilova SI, Zharikov GA. Gavrilova SI, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2003;103(12):59-65. Zh Nevrol Psikhiatr Im S S Korsakova. 2003. PMID: 14763262 Review. Russian. No abstract available.
FDA approves galantamine for Alzheimer's disease.
Thompson CA. Thompson CA. Am J Health Syst Pharm. 2001 Apr 15;58(8):649. doi: 10.1093/ajhp/58.8.649a. Am J Health Syst Pharm. 2001. PMID: 11329755 No abstract available.
Therapeutic continuity in Alzheimer's disease: switching patients to galantamine. Introduction.
Morris JC. Morris JC. Clin Ther. 2001;23 Suppl A:A1-2. doi: 10.1016/s0149-2918(01)80161-2. Clin Ther. 2001. PMID: 11396866 No abstract available.
Galantamine (reminyl) for Alzheimer's disease.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2001 Jun 25;43(1107):53-4. Med Lett Drugs Ther. 2001. PMID: 11426189 No abstract available.
Therapeutic continuity in Alzheimer's disease: switching patients to galantamine. Panel discussion: recommendations for prescribers.
Morris JC, Farlow MR, Ferris SH, Kurz AF, Maelicke A, Rasmusen L, Wilkinson D, Yan B. Morris JC, et al. Clin Ther. 2001;23 Suppl A:A31-9. doi: 10.1016/s0149-2918(01)80166-1. Clin Ther. 2001. PMID: 11396870 No abstract available.
Galantamine vs donepezil in the treatment of Alzheimer's disease.
Goldlist B, Gordon M, Naglie G. Goldlist B, et al. Drugs Aging. 2003;20(15):1139-40; author reply 1140. doi: 10.2165/00002512-200320150-00009. Drugs Aging. 2003. PMID: 14651439 No abstract available.
[Pharmacotherapy of a patient with Alzheimer's disease: interactions with the antidementive galantamine].
Schwalbe O, Wunderlich S, Kloft C. Schwalbe O, et al. Med Monatsschr Pharm. 2006 Jun;29(6):222-4. Med Monatsschr Pharm. 2006. PMID: 16792199 German.
Update on Alzheimer drugs (galantamine).
Raskind MA. Raskind MA. Neurologist. 2003 Sep;9(5):235-40. doi: 10.1097/01.nrl.0000087722.46430.c4. Neurologist. 2003. PMID: 12971834 Review.
Comparative analysis of mortality in patients with Alzheimer's disease treated with donepezil and galantamine.
Capellà D, Vidal X. Capellà D, et al. Age Ageing. 2007 Mar;36(2):234; author reply 235. doi: 10.1093/ageing/afl169. Epub 2007 Jan 25. Age Ageing. 2007. PMID: 17255086 No abstract available.
100 results
Jump to page
Feedback